POTENTIAL HARMS OF THE USE OF PROTON PUMP INHIBITORS: DEBATABLE PROBLEMS

POTENTIAL HARMS OF THE USE OF PROTON PUMP INHIBITORS: DEBATABLE PROBLEMS

The paper discusses data on the high frequency of non-indicated use of proton pump inhibitors and on the manifestations of potential harms of their use.

Dettagli Bibliografici
Autori principali:	Yu. V. Muravyev, O. R. Bobkova
Natura:	Articolo
Lingua:	Russian
Pubblicazione:	IMA PRESS LLC 2018-11-01
Serie:	Научно-практическая ревматология
Soggetti:	proton pump inhibitors harm rheumatoid arthritis hypersensitivity reactions
Accesso online:	https://rsp.mediar-press.net/rsp/article/view/2634

Documenti analoghi

Adherence with proton pump inhibitor therapy, by continuously taking nonsteroidal anti-inflammatory drugs
di: S I Pimanov, et al.
Pubblicazione: (2015-04-01)

Proton pump inhibitors overuse - consequences among patients
di: Patrycja Kmiotek, et al.
Pubblicazione: (2019-08-01)

Proton pump inhibitors overuse - consequences among patients
di: Patrycja Kmiotek, et al.
Pubblicazione: (2019-08-01)

Proton pump inhibitors overuse: only inappropriate prescriptions or further iatrogenic damage?
di: Mario Visconti
Pubblicazione: (2015-09-01)

Proton Pump Inhibitors and Gastric Cancer
di: Seungkyung Kang, et al.
Pubblicazione: (2021-09-01)

Safety and Potential Risks of Prolonged Use of Proton Pump Inhibitors
di: S.M. Tkach
Pubblicazione: (2014-02-01)

Proton pump inhibitor alters Th17/Treg balance and induces gut dysbiosis suppressing contact hypersensitivity reaction in mice
di: Anna Strzępa, et al.
Pubblicazione: (2024-08-01)

Omeprazole was safely reused in a rhabdomyolysis patient associated with proton pump inhibitors: A case report
di: Zhen Wang, et al.
Pubblicazione: (2023-11-01)

Clinicopathologic Analysis of Proton Pump Inhibitor-Responsive Esophageal Eosinophilia in Korean Patients
Pubblicazione: (2016-01-01)

Deprescribing of Inappropriately Consumed Proton Pump Inhibitors and its Clinical Consequences
di: Apoorva Rachana Kulkarni, et al.
Pubblicazione: (2021-08-01)

Proton pump inhibitors to control phosphorus levels in hemodialysis patients
di: Amineh Hojati
Pubblicazione: (2025-10-01)

Incidence of hypomagnesemia on proton pump inhibitors at the Huntington Veterans Affairs Medical Center – IHOP
di: Ebrahim Sabbagh, et al.
Pubblicazione: (2016-07-01)

Proton pump inhibitors and dementia: what association?
di: Catarina Caetano, et al.
Pubblicazione: (2023-05-01)

Proton pump inhibitors usage and the risk of cancer
di: Hubert Wróblewski, et al.
Pubblicazione: (2021-08-01)

Gastroesophageal reflux disease, resistant to proton pump inhibitors
di: V. O. Kaybysheva, et al.
Pubblicazione: (2011-06-01)

Proton Pump Inhibitors: Are They a Real Threat to the Patient?
di: Sofia Xavier, et al.
Pubblicazione: (2018-02-01)

Proton pump inhibitors: potential cost reductions by applying prescribing guidelines
di: Cahir Caitriona, et al.
Pubblicazione: (2012-11-01)

A dual role of proton pump inhibition on cancer: a critical review
di: Edizer Deniz Tuna, et al.
Pubblicazione: (2023-02-01)

PPI adverse drugs reactions: a retrospective study
di: Marco Casciaro, et al.
Pubblicazione: (2019-01-01)

Proton pump inhibitors induce hemolytic anemia
di: Asayil Nasser Al-Nasser, et al.
Pubblicazione: (2019-01-01)

Effects of proton pump inhibitor use on the esophageal microbial community
di: Sadia Tasnim, et al.
Pubblicazione: (2020-09-01)

Prescription Pattern of Proton Pump Inhibitors at Hospital Admission and Discharge
di: Verónica Gamelas, et al.
Pubblicazione: (2018-05-01)

Effect of Proton Pump Inhibitors in Bronchiectatic Patients with Gastroesophageal Reflux Disease
di: Byungkyu Ahn, et al.
Pubblicazione: (2016-07-01)

Influence of proton pump inhibitor therapy on intestinal inflammation assessed by fecal calprotectin in pediatric patients
di: Su Yeong Kim, et al.
Pubblicazione: (2019-10-01)

Proton-pump inhibitors
di: Vasudevan G. Naidoo
Pubblicazione: (2015-05-01)

The Perilous PPI: Proton Pump Inhibitor as a Cause of Clinically Significant Hypomagnesaemia
di: Yong Ting Tai, et al.
Pubblicazione: (2020-04-01)

Clinical Significance of Changes in Gut Microbiome Associated with Use of Proton Pump Inhibitors
di: Tae Jun Kim, et al.
Pubblicazione: (2020-09-01)

Proton-pump Inhibitors and the Risk of Dementia: A Systematic Review and Meta-analysis
di: Kyu-Tae Yoon, et al.
Pubblicazione: (2021-06-01)

Meniere’s disease and the use of proton pump inhibitors
di: A Pirodda, et al.
Pubblicazione: (2010-09-01)

METHOTREXATE AND PROTON PUMP INHIBITORS: ARE THERE ANY NEGATIVE PHARMACOLOGIAL EFFECTS?
di: Andrey E Karateev, et al.
Pubblicazione: (2014-02-01)

25 Years of Proton Pump Inhibitors: A Comprehensive Review
di: Daniel S. Strand, et al.
Pubblicazione: (2017-01-01)

Proton pump inhibitors and risk for Clostridium difficile associated diarrhea
di: Sasmita Biswal
Pubblicazione: (2014-08-01)

The effect of proton pump inhibitors on glycaemic control in diabetic patients
di: Muhammad Ali Rajput, PhD, et al.
Pubblicazione: (2020-06-01)

Pointing the finger at proton pump inhibitors
di: Emma L Walton
Pubblicazione: (2014-08-01)

Proton pump inhibitor deprescription: A rapid review
di: Renata Rodriguez Imparato, et al.
Pubblicazione: (2022-07-01)

Pharmacogenetics of proton pump inhibitors
di: M. V. Leonova
Pubblicazione: (2015-12-01)

Potential adverse effects of long term use of Proton Pump Inhibitors
di: Shreyans M. Doshi, et al.
Pubblicazione: (2016-07-01)

Changes in serum magnesium concentration after use of a proton pump inhibitor in patients undergoing percutaneous coronary intervention
di: Sang-Ho Park, et al.
Pubblicazione: (2015-06-01)

The Positive Association between Proton Pump Inhibitors and Clostridium Difficile Infection
di: Dania Tawam, et al.
Pubblicazione: (2021-03-01)

Anaphylaxis as a Rare Side Effect of Pantoprazole; a Case Report
di: Gholamreza Faridaalaee, et al.
Pubblicazione: (2018-05-01)